NEW YORK (GenomeWeb News) – Monsanto today announced it has acquired some of the assets of genomics-based plant breeding firm Agradis, a little more than one year after the company was formed by J. Craig Venter's Synthetic Genomics and Mexican investment and management firm Plenus.

Included in the assets purchased by Monsanto are the Agradis name, its collection of microbes for improving crop productivity, and Agradis' R&D site in La Jolla, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.